EIF4E and chronic myelogenous leukemia, BCR-ABL1 positive: Niclosamide inhibits the phosphorylation of the ERK, Mnk1, and eIF4E signaling pathways, and it also inhibits the proliferation of and induces apoptosis in chronic myeloid leukemia cells [37].